Varian Medical Financial Statements (VAR)
|
|
|
|
Report date
|
|
|
23.11.2016 |
27.11.2017 |
26.11.2018 |
25.11.2019 |
25.11.2020 |
|
09.02.2021 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
3 218 |
2 619 |
2 919 |
3 225 |
3 168 |
|
6 504 |
|
Operating Income, bln rub |
|
|
567.7 |
300.2 |
437.4 |
386.2 |
0.000 |
|
-449.6 |
|
EBITDA, bln rub |
? |
|
647.6 |
393.8 |
531.2 |
516.1 |
60.0 |
|
-412.0 |
|
Net profit, bln rub |
? |
|
402.3 |
218.5 |
149.9 |
291.9 |
0.000 |
|
-385.2 |
|
|
OCF, bln rub |
? |
|
356.3 |
399.1 |
454.9 |
371.8 |
785.0 |
|
272.0 |
|
CAPEX, bln rub |
? |
|
80.4 |
59.1 |
47.7 |
58.0 |
84.0 |
|
90.0 |
|
FCF, bln rub |
? |
|
275.9 |
340.0 |
407.2 |
313.8 |
701.0 |
|
182.0 |
|
Dividend payout, bln rub
|
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
|
|
0 |
|
|
OPEX, bln rub |
|
|
793.6 |
813.7 |
836.2 |
984.1 |
1 054 |
|
2 114 |
|
Cost of production, bln rub |
|
|
1 857 |
1 505 |
1 646 |
1 855 |
1 791 |
|
3 630 |
|
R&D, bln rub |
|
|
253.5 |
210.0 |
233.9 |
247.6 |
280.0 |
|
574.0 |
|
Interest expenses, bln rub |
|
|
11.8 |
10.7 |
6.80 |
8.80 |
14.0 |
|
26.0 |
|
|
Assets, bln rub |
|
|
3 816 |
3 294 |
3 253 |
4 102 |
3 841 |
|
3 879 |
|
Net Assets, bln rub |
? |
|
1 741 |
1 518 |
1 584 |
1 768 |
2 075 |
|
2 238 |
|
Debt, bln rub |
|
|
667.1 |
350.0 |
0.000 |
410.0 |
355.0 |
|
210.0 |
|
Cash, bln rub |
|
|
938.8 |
716.2 |
544.2 |
531.4 |
766.0 |
|
773.0 |
|
Net debt, bln rub |
|
|
-271.7 |
-366.2 |
-544.2 |
-121.4 |
-411.0 |
|
-563.0 |
|
|
Ordinary share price, rub |
|
|
99.5 |
100.1 |
111.9 |
118.2 |
171.9 |
|
177.1 |
|
Number of ordinary shares, mln |
|
|
95.4 |
92.0 |
92.0 |
91.0 |
91.0 |
|
91.2 |
|
|
Market cap, bln rub |
|
|
9 495 |
9 206 |
10 298 |
10 753 |
15 646 |
|
16 154 |
|
EV, bln rub |
? |
|
9 223 |
8 839 |
9 753 |
10 631 |
15 235 |
|
15 591 |
|
Book value, bln rub |
|
|
1 341 |
1 223 |
1 190 |
855 |
1 181 |
|
1 346 |
|
|
EPS, rub |
? |
|
4.22 |
2.38 |
1.63 |
3.21 |
0.00 |
|
-4.22 |
|
FCF/share, rub |
|
|
2.89 |
3.70 |
4.43 |
3.45 |
7.70 |
|
2.00 |
|
BV/share, rub |
|
|
14.1 |
13.3 |
12.9 |
9.40 |
13.0 |
|
14.8 |
|
|
EBITDA margin, % |
? |
|
20.1% |
15.0% |
18.2% |
16.0% |
1.89% |
|
-6.33% |
|
Net margin, % |
? |
|
12.5% |
8.34% |
5.14% |
9.05% |
0.00% |
|
-5.92% |
|
FCF yield, % |
? |
|
2.91% |
3.69% |
3.95% |
2.92% |
4.48% |
|
1.13% |
|
ROE, % |
? |
|
23.1% |
14.4% |
9.46% |
16.5% |
0.00% |
|
-17.2% |
|
ROA, % |
? |
|
10.5% |
6.63% |
4.61% |
7.12% |
0.00% |
|
-9.93% |
|
|
P/E |
? |
|
23.6 |
42.1 |
68.7 |
36.8 |
|
|
-41.9 |
|
P/FCF |
|
|
34.4 |
27.1 |
25.3 |
34.3 |
22.3 |
|
88.8 |
|
P/S |
? |
|
2.95 |
3.51 |
3.53 |
3.33 |
4.94 |
|
2.48 |
|
P/BV |
? |
|
7.08 |
7.52 |
8.66 |
12.6 |
13.2 |
|
12.0 |
|
EV/EBITDA |
? |
|
14.2 |
22.4 |
18.4 |
20.6 |
253.9 |
|
-37.8 |
|
Debt/EBITDA |
|
|
-0.42 |
-0.93 |
-1.02 |
-0.24 |
-6.85 |
|
1.37 |
|
|
R&D/CAPEX, % |
|
|
315.3% |
355.3% |
490.4% |
426.9% |
333.3% |
|
637.8% |
|
|
CAPEX/Revenue, % |
|
|
2.50% |
2.26% |
1.63% |
1.80% |
2.65% |
|
1.38% |
|
| Varian Medical shareholders |
